Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,944,719 | 1,735,696 | 2,863,619 | 3,023,172 | 3,154,263 |
| Marketable Securities | 102,944 | 367,182 | 349,978 | 407,166 | 260,896 |
| Receivables | 3,575,353 | 3,518,446 | 3,577,397 | 3,184,174 | 3,084,455 |
| Inventories | 2,583,053 | 2,619,642 | 2,335,159 | 2,406,340 | 2,222,641 |
| Other current assets | 1 | 1 | -1 | 0 | 0 |
| TOTAL | $9,206,070 | $8,240,967 | $9,126,152 | $9,020,852 | $8,722,255 |
| Non-Current Assets | |||||
| PPE Net | 6,079,157 | 5,965,724 | 5,354,020 | 5,234,224 | 4,716,235 |
| Investments And Advances | 243,512 | 257,556 | 267,648 | 349,654 | 296,096 |
| Intangibles | 671,940 | 666,179 | 505,068 | 413,170 | 391,491 |
| Other Non-Current Assets | 329,326 | 316,002 | 294,838 | 448,878 | 342,241 |
| TOTAL | $7,323,935 | $7,205,460 | $6,421,573 | $6,445,926 | $5,746,063 |
| Total Assets | $16,530,000 | $15,446,430 | $15,547,720 | $15,466,780 | $14,468,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 39,545 | 37,643 | 257,319 | 41,080 | 248,916 |
| Accounts payable and accrued liabilities | 933,383 | 679,717 | 852,159 | 715,740 | 629,610 |
| Other current liabilities | 6,359,012 | 5,899,023 | 5,393,969 | 5,493,976 | 5,054,926 |
| TOTAL | $7,873,558 | $7,292,137 | $7,147,807 | $7,130,066 | $6,481,570 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 722,371 | 720,001 | 704,512 | 704,680 | 738,908 |
| TOTAL | $798,579 | $850,595 | $833,020 | $919,244 | $823,064 |
| Total Liabilities | $8,672,137 | $8,142,732 | $7,980,826 | $8,049,310 | $7,304,633 |
| Shareholders' Equity | |||||
| Common Shares | 78,449 | 82,550 | 75,950 | 79,000 | 73,950 |
| Retained earnings | 8,112,427 | 7,206,945 | 7,439,606 | 7,151,396 | 6,953,371 |
| Other shareholders' equity | -332,008 | 16,199 | 53,342 | 188,072 | 137,364 |
| TOTAL | $7,857,868 | $7,303,694 | $7,566,898 | $7,417,468 | $7,163,685 |
| Total Liabilities And Equity | $16,530,005 | $15,446,426 | $15,547,724 | $15,466,778 | $14,468,318 |